Schaible Hans-Georg
Institute of Physiology I/Neurophysiology, Jena University Hospital - Friedrich Schiller University, Teichgraben 8, Jena, D-07740, Germany.
Arthritis Res Ther. 2014;16(5):470. doi: 10.1186/s13075-014-0470-8.
Proinflammatory cytokines are major mediators in the pathogenesis of diseases of joints such as rheumatoid arthritis and osteoarthritis. This review emphasizes that proinflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-17 are also mediators of pain by directly acting on the nociceptive system. Proportions of nociceptive sensory neurons express receptors for these cytokines, and the application of cytokines rapidly changes the excitability, ion currents and second messenger systems of these neurons. By inducing persistent sensitization of nociceptive sensory neurons (C- and a proportion of Aδ-fibers) for mechanical stimuli in the joint (a process called peripheral sensitization), these cytokines significantly contribute to the persistent hyperalgesia typical for many disease states of the joint. In addition, the disease-associated release of cytokines in the spinal cord supports the generation of central sensitization. The therapeutic neutralization of proinflammatory cytokines thus not only reduces the process of inflammation but may directly reduce hyperalgesia and pain by reversing the neuronal effects of cytokines. It is emerging that different cytokines have different actions on neurons. The neutralization of tumor necrosis factor-alpha reduces both mechanical and thermal hyperalgesia of the joint. The neutralization of interleukin-1 beta attenuates thermal hyperalgesia whereas the neutralization of interleukin-6 and interleukin-17 mainly reduces mechanical hyperalgesia. These different effects are partly explained by influencing different target molecules in sensory neurons. For example, in cultured sensory neurons tumor necrosis factor-alpha and interleukin-1 beta upregulate the TRPV1 ion channel, which is involved in the transduction of heat stimuli, consistent with an effect of these cytokines in thermal hyperalgesia. By contrast, interleukin-17 upregulates the TRPV4 ion channel, which has a role in the transduction of mechanical stimuli. Thus, the analgesic potential of neutralizing cytokines seems to depend on which cytokine is mainly involved in the particular pain state.
促炎细胞因子是类风湿性关节炎和骨关节炎等关节疾病发病机制中的主要介质。本综述强调,肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6和白细胞介素-17等促炎细胞因子也是疼痛的介质,它们通过直接作用于伤害感受系统发挥作用。一定比例的伤害性感觉神经元表达这些细胞因子的受体,细胞因子的应用会迅速改变这些神经元的兴奋性、离子电流和第二信使系统。通过诱导关节中伤害性感觉神经元(C纤维和一部分Aδ纤维)对机械刺激的持续敏化(这一过程称为外周敏化),这些细胞因子显著促成了许多关节疾病状态下典型的持续性痛觉过敏。此外,脊髓中与疾病相关的细胞因子释放支持中枢敏化的产生。因此,对促炎细胞因子进行治疗性中和不仅可以减轻炎症过程,还可能通过逆转细胞因子对神经元的作用直接减轻痛觉过敏和疼痛。越来越多的研究表明,不同的细胞因子对神经元有不同的作用。肿瘤坏死因子-α的中和可减轻关节的机械性和热性痛觉过敏。白细胞介素-1β的中和可减轻热性痛觉过敏,而白细胞介素-6和白细胞介素-17的中和主要减轻机械性痛觉过敏。这些不同的作用部分是由于它们影响了感觉神经元中的不同靶分子。例如,在培养的感觉神经元中,肿瘤坏死因子-α和白细胞介素-1β上调参与热刺激转导的TRPV1离子通道,这与这些细胞因子在热性痛觉过敏中的作用一致。相比之下,白细胞介素-17上调参与机械刺激转导的TRPV4离子通道。因此,中和细胞因子的镇痛潜力似乎取决于哪种细胞因子主要参与特定的疼痛状态。